FDA Inspection 1177460 — Outin Futures Corp

Outin Futures Corp — FEI 3011572099

The FDA completed an inspection of Outin Futures Corp on Aug 12, 2022 in Chungju. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Aug 12, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chungju (Korea (the Republic of))

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
122721 CFR 211.67(c)Cleaning/maintenance records not kept
136121 CFR 211.100(a)Absence of Written Procedures
192721 CFR 211.166(b)Accelerated stability studies
359221 CFR 211.110(c)In-process materials characteristics testing
360321 CFR 211.160(b)Scientifically sound laboratory controls
360921 CFR 211.160(b)(2)In-process sample representation/identification

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.